AstraZeneca has probably the best antibiotic pipeline in the industry. It's also a business they no longer want to be in.
Their departure would follow on the heels of Pfizer exiting that segment, leaving GlaxoSmithKline and Merck.
Why? Well, pharmaceuticals in general in crisis. I have likened it to the US steel industry in the 1970s. Critics think if they are still making money, it must be okay and they can hammer on them indefinitely. But that isn't how business works. If government-controlled academia has to take over pharmaceutical development, we are doomed.
Credit: Life Sciences Foundation
Antibiotic resistance happens, there is no escaping it. To combat that, we need new antibiotics, plain and simple. But for regulatory bodies and anti-science activists, drug companies are open season for cultural sniping.
UK Prime Minister David Cameron is setting up a task force to come up with a policy for antibiotic resistance. Meanwhile, the company with the best products on the horizon is in the UK - and trying to jettison that business.
The solution seems simple: stop treating drug companies like they are the enemy. Development is horrifically expensive, they get a short window to sell it before it goes generic, and they are criticized for trying to make their money back. If anything goes wrong despite a hundred million dollars in tests, they are sued.
That's not a return on investment anyone wants to risk.
Can David Cameron Save AZ's Antibiotics? by David Shlaes
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Erupting Bardarbunga Volcano In Iceland Sits On A Massive Magma Hot Spot
- Genetically Modified Stem Cells Kill Brain Tumors
- Researchers Created A Laser Bullet To See What It Would Look Like - And Here It Is
- How Gut Bacteria Ensure A Healthy Brain – and Could Play A Role In Treating Depression
- Psychiatry Should Switch From Symptom-based Prescriptions To Target-based
- Cold Fusion: A Better Study On The Infamous E-Cat
- Ebola's Evolutionary Roots Are Ancient
- "If we had a contest between the USA and UK, perhaps weighted according to population or GDP, which..."
- "Hi Tommaso,I stumbled on this presentation; the plot on slide nr. 4 might be of interest to you..."
- "Hi Dhrou,of course the HL-LHC lumi leveling is different from the LHCb one - a glance at the plot..."
- "Sorry but a ridiculous test made by an anonymous source does not even qualify to be discussed here..."
- "/* Science advances as much by mistakes as by plans. */ Apparently the mainstream physicists are..."
- How to sell a toxic pesticide the smart way–call it organic
- Leftist dystopia? Anti-technology fever animates opposition to GMOs and other ‘disruptive’ technologies
- CDC faced a nearly impossible balancing act with Ebola, and failed
- Why Chobani reversed course, making yoghurt only from milk from cows not fed GMO grain
- Monterey, California, hotbed of anti-GMO activism, home to new GMO corn farm
- Evolution is sometimes messy or even outright ridiculous